Table 8.
Activities of gluconeogenic enzymes in the kidney of control and experimental rats.
| Group | Glucose-6-phosphatase (n moles of Pi liberated/min/mg protein) | Fructose-1,6-diphosphatase (n moles of Pi liberated/min/mg protein) |
|---|---|---|
| C | 50.74 ± 4.03 | 22.1 ± 2.98 |
| A | 129.18 ± 5.10 | 219.88 ± 5.13 |
| A + M100 | 70.2 ± 7.45∗ | 40.32 ± 4.39∗ |
| A + M200 | 59.8 ± 5.16∗ | 33.62 ± 4.29∗ |
| A + M500 | 48.12 ± 1.71∗ | 26.02 ± 1.60∗ |
| A + G500 | 74.08 ± 9.51∗ | 45.16 ± 5.74∗ |
| A + G750 | 62.12 ± 6.09∗ | 38.94 ± 3.38∗ |
| A + G1000 | 49.14 ± 2.58∗ | 34.24 ± 4.46∗ |
| M100 | 52.18 ± 4.56 | 22.1 ± 2.99 |
| M200 | 50.16 ± 2.9 | 20.64 ± 2.38 |
| M500 | 49.38 ± 1.94 | 24.38 ± 2.22 |
| G 500 | 50.94 ± 3.40 | 21.04 ± 3.49 |
| G 750 | 51.04 ± 3.80 | 19.54 ± 1.84 |
| G 1000 | 51.34 ± 3.09 | 21.54 ± 2.45 |
∗ p < 0.05 indicates a significant difference from the disease group (C = control group, A = alloxan-treated group, M = metformin, A + M = alloxan + metformin, A + G = alloxan + Gynura, and G = G. procumbens).